
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase
Francis J. Giles, Eric J. Feldman, Gail J. Roboz, Richard A. Larson, Steven W. Mamus, Jorge E. Cortes, Srdan Verstovsek, Stefan Faderl, Moshe Talpaz, Miloslav Beran, Maher Albitar, Susan M. O’Brien, HVolume:
27
Année:
2003
Langue:
english
Pages:
6
DOI:
10.1016/s0145-2126(03)00094-8
Fichier:
PDF, 72 KB
english, 2003